Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B262279a14967d4b364f6173e5b6e7135> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B262279a14967d4b364f6173e5b6e7135 NCIT_P378 "CDISC-GLOSS" @default.
- B262279a14967d4b364f6173e5b6e7135 type Axiom @default.
- B262279a14967d4b364f6173e5b6e7135 annotatedProperty NCIT_P325 @default.
- B262279a14967d4b364f6173e5b6e7135 annotatedSource NCIT_C165835 @default.
- B262279a14967d4b364f6173e5b6e7135 annotatedTarget "Medicinal products identified in the protocol as those that may be administered to subjects when the efficacy of the investigational medicinal product (IMP) is not satisfactory, the effect of the IMP is too great and is likely to cause a hazard to the patient, or to manage an emergency situation. [After EU-CTR Recommendations from the expert group on clinical trials for the implementation of Regulation (EU) No 536/2014' dd 28 June 2017]" @default.